Manufacturer
163 recalls in our database name Dr. Reddy's Laboratories, Inc. as the manufacturing or recalling firm.
Of the 163 recalls from Dr. Reddy's Laboratories, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 30 (18%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Dr. Reddy's is recalling specific lots of Amlodipine and Atorvastatin tablets because they contain less active ingredient than labeled.
Dr. Reddy's Laboratories is voluntarily recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain less than the labeled amount of active ingredients.
Dr. Reddy's is recalling specific lots of Metoprolol Succinate Extended Release Tablets because they failed dissolution testing at 18 months.
Dr. Reddy's is recalling multiple brands of Lansoprazole Delayed Release Capsules due to out-of-specification microbial counts.
Dr. Reddy's is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed dissolution specifications and a 12-month stability interval.
Dr. Reddy's Laboratories is recalling IBU (Ibuprofen) 800 mg tablets because the bottles display an incorrect expiration date of 05/2017 instead of 10/2016.
Dr. Reddy's is recalling specific lots of OTC Ranitidine Hydrochloride tablets because raw material tested positive for Pseudomonas sp.
Dr. Reddy's is recalling 86,093 bottles of Citalopram tablets due to reports of a strong garlic or chemical smell.
Dr. Reddy's is recalling specific lots of Citalopram tablets because patients reported a strong garlic or chemical smell.
Dr. Reddy's is recalling 27,805 bottles of Citalopram tablets 10mg due to reports of a strong garlic or chemical smell.
Dr. Reddy's is recalling Quetiapine Fumarate Tablets, 25mg, because they failed USP dissolution testing during stability studies.
Dr. Reddy's is recalling Amlodipine Besylate and Benazepril Hydrochloride capsules because bottles were mislabeled and contained foreign Ciprofloxacin tablets.
Dr. Reddy's is recalling Ciprofloxacin Tablets due to complaints of mislabeled bottles containing foreign tablets.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Dr Reddy's Laboratories (Switzerland)
Source: Wikidata (Q30343911), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.